Financings Of The Fortnight: Follow-On Fever
This article was originally published in The Pink Sheet Daily
Executive Summary
Does the recent rash of follow-on public offerings mean biotech IPOs are around the corner? Recent financings provide reason to think it's possible.
You may also be interested in...
VCs Must Get Back To Basics And Fund Innovation - MassBio Panel
Now that the "me too" era is over, venture capitalists should turn back to building innovative biotech companies, panelists at MassBio's annual meeting say.
VCs Must Get Back To Basics And Fund Innovation - MassBio Panel
Now that the "me too" era is over, venture capitalists should turn back to building innovative biotech companies, panelists at MassBio's annual meeting say.
Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals
Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.